Back to Search Start Over

Coherus BioSciences submits BLA for CHS-1701 with US FDA

Source :
M2 Communications. January 15, 2017
Publication Year :
2017

Abstract

Oct 11, 2016 (M2 EQUITYBITES via COMTEX) -- Biosimilar company Coherus BioSciences Inc (NasdaqGM:CHRS) stated on Thursday that it has successfully filed a 351(k) Biologics License Application for CHS-1701 with [...]

Details

Language :
English
Database :
Gale General OneFile
Journal :
M2 Communications
Publication Type :
News
Accession number :
edsgcl.477593019